Correction: Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Systematic characterization of cell type-specific master metabolic regulators in Alzheimer's disease.Research square · 2025
   Article
2. Cell type-specific master metabolic regulators of Alzheimer's disease.bioRxiv : the preprint server for biology · 2025
   Article
3. Possible Role of Cellular Polyamine Metabolism in Neuronal Apoptosis.Current medical science · 2024
   Article
4. Cross-species metabolomic analysis of tau- and DDT-related toxicity.PNAS nexus · 2022
   Article

Corrections and comments

• Erratum for
  Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study.2020

Authors and funding

13 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract